Two decades ago, both medtech and healthtech were in the early phases of development. Robotic-assisted surgery was beginning to gain traction, consumer-facing healthtech was in its infancy, and the idea of personalized medicine was only just starting to emerge with the completion of the Human Genome Project.

At that time, LSI was also just getting started. We were sending printed medtech market reports in three-ring binders, making event invitations over landlines, and navigating an industry still defining its future.

A lot has changed since then.

Just as the medtech industry evolved into a global driver of innovation, LSI has transformed how we support the community—from data delivery to strategic networking opportunities. We’re proud to embark on our most ambitious step yet: the launch of LSI Asia, our third global summit, premiering June 10-13, 2025, at The Ritz-Carlton, Millenia Singapore.

This new summit reflects the growing importance of the APAC medtech market and our commitment to building a truly global platform for innovation, investment, and partnership.

Why Now: The APAC Medtech Market Is Surging

The Asia-Pacific region has reached a major inflection point in its role in the future of healthcare innovation. What was once seen as a secondary or emerging market has quickly become a nucleus for next-generation technologies, from AI-powered diagnostics to robotics, advanced imaging, and digital therapeutics.

It’s not just the innovation that’s driving attention—investment activity across the region is accelerating, and major strategics have already placed key footholds in countries like China, Singapore, South Korea, and India. As projected by LSI’s Market Intelligence team, China is on track to surpass the United States in total surgical procedure volume in the coming years. Four of the five fastest-growing countries in terms of surgical volume are now located in Asia (e.g., Singapore).

The APAC medtech sector is no longer a future consideration. It’s a current and essential growth driver for companies worldwide.

For startups, this means access to increasingly sophisticated venture ecosystems. For strategics, it’s a region that demands close engagement. And for investors, it represents both a capital opportunity and a global responsibility to fuel impactful innovation.

The timing is right. The need is clear. The opportunity is massive.

Why Singapore: A Thriving Medtech Gateway

When selecting a home for our first APAC summit, Singapore stood out as the clear choice.

Few cities in the world have built such a compelling environment for medtech startups and healthcare innovation. Thanks to strong government support, top-tier academic institutions, active family offices, sovereign wealth funds, and institutional investors, Singapore offers a uniquely fertile ground for scaling ideas into global businesses.

The city’s infrastructure for medical device development, from R&D to regulatory to manufacturing, is highly advanced. Local startups are already delivering commercial-stage technologies that compete on a global level.

Add to that Singapore’s central location and accessibility within Southeast Asia, and it becomes the ideal meeting point for executives from across the region—and a natural extension of LSI’s existing global community.

Of course, the venue matters too. The Ritz-Carlton, Millenia Singapore, will serve as the setting for LSI Asia ‘25. With world-class accommodations, exceptional dining, and state-of-the-art facilities, the location aligns with our commitment to fostering high-impact, in-person collaboration.

We’ve designed this summit to bring together senior leaders for real business conversations in a setting that matches the caliber of the work being done.

Building Toward the Future in APAC

LSI Asia is more than just a new event—it’s a strategic initiative that reflects our belief in the long-term potential of the APAC region.

For years, our Emerging Medtech Summits in the USA and Europe have helped founders, investors, and strategics navigate the path from early innovation to commercial success. The launch of our third summit signals a new chapter in that mission, where we don’t just observe growth; we help accelerate it.

Our goal is to support the region’s next generation of category-defining companies by offering them access to the same community, capital, and insights that have helped hundreds of startups scale globally through LSI’s platform.

In turn, we believe this initiative will also help executives from outside Asia understand how to better engage with the region, identify meaningful opportunities, and build lasting cross-border partnerships.

What You Can Expect at LSI Asia ‘25

LSI Asia ‘25 will bring together innovators, investors, strategics, and key partners from across the global medtech and healthtech landscape. Attendees will gain access to:

• Startup presentations from emerging companies across APAC and beyond

• Keynotes, fireside chats, and workshops with leading voices shaping healthcare innovation

• Curated one-on-one partnering opportunities

• A high-value networking environment tailored for dealmaking

Whether you’re looking to raise capital, identify acquisition targets, scout technologies, or simply gain a deeper understanding of the APAC medtech landscape, this event is designed to deliver real outcomes.

Join Us in Singapore

The launch of LSI Asia marks a defining moment for LSI and, we believe, for the broader APAC medtech community.

This expansion allows us to support healthcare innovation in one of the most dynamic and fast-growing regions in the world. It also offers our partners from every geography a new opportunity to build global connections, discover emerging technologies, and help bring life-changing solutions to more patients, faster.

We invite you to be part of this next step in our journey.

Register today, apply to present, or explore sponsorship and speaking opportunities by visiting the LSI Asia homepage.

Together, we’ll continue building the future of medtech—one summit, one conversation, and one breakthrough at a time.